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Abstract
Background: The host response to influenza A infections is strongly influenced by host genetic factors. Animal
models of genetically diverse mouse strains are well suited to identify host genes involved in severe pathology, viral
replication and immune responses. Here, we have utilized a dual RNAseq approach that allowed us to investigate
both viral and host gene expression in the same individual mouse after H1N1 infection.
Results: We performed a detailed expression analysis to identify (i) correlations between changes in expression of
host and virus genes, (ii) host genes involved in viral replication, and (iii) genes showing differential expression
between two mouse strains that strongly differ in resistance to influenza infections. These genes may be key
players involved in regulating the differences in pathogenesis and host defense mechanisms after influenza A
infections. Expression levels of influenza segments correlated well with the viral load and may thus be used as
surrogates for conventional viral load measurements. Furthermore, we investigated the functional role of two
genes, Reg3g and Irf7, in knock-out mice and found that deletion of the Irf7 gene renders the host highly
susceptible to H1N1 infection.
Conclusions: Using RNAseq analysis we identified novel genes important for viral replication or the host defense.
This study adds further important knowledge to host-pathogen-interactions and suggests additional candidates
that are crucial for host susceptibility or survival during influenza A infections.
Background
Influenza A viruses have an adverse impact on human and
animal health worldwide through seasonal epidemics,
newly emerging pandemics, and reoccurring outbreaks in
livestock. The most severe human pandemic in 1918 re-
sulted in about 30 million fatal casualties [1]. In addition,
seasonal influenza infections represent a major health haz-
ard causing deaths and enormous losses of work force
every year [2].
We and others have shown in animal models that the
genetic background of the host strongly influences mortal-
ity and morbidity after influenza infections. In particular,
major differences in susceptibility and resistance were
observed between different mouse inbred strains [3–13].
Detailed analysis of the mouse strains C57BL/6J and
DBA/2J revealed that C57BL/6J mice survived infections
with a low pathogenic A/Puerto Rico/8/1934 H1N1 virus
(PR8M) whereas DBA/2J mice rapidly lost weight and all
infected mice died [3, 14]. Infected DBA/2J had higher
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viral loads in their lungs and also exhibited a stronger
inflammatory response compared to C57BL/6J mice
[3, 14, 15]. Therefore, the comparison of these two
mouse strains represents a very suitable model system
to identify genes that are associated with severe infec-
tion outcomes in humans [16].
During an acute influenza virus infection, highly dy-
namic and inter-related responses are triggered in the
host which eventually results in clearance of the patho-
gen and establishment of a long-lasting immunity. We
recently demonstrated that these host responses can be
studied comprehensively by measuring changes in the
gene expression levels after infection [17, 18].
Here, we expanded those earlier studies by utilizing a
dual RNAseq approach that enabled us to investigate
both virus as well as host gene expression in the same
individual. We found several new host genes that are
strongly correlated with virus gene expression. Host
genes potentially involved in viral replication were iden-
tified by comparisons with candidates from previous
siRNA studies. In addition, we identified host genes that
exhibit differential expression between the C57BL/6J and
DBA/2J mouse strains after infection. These genes may
be crucial to direct the host response to influenza A in-
fections and be causal for differences in susceptibility
and resistance of genetically diverse hosts to influenza or
other viral infections. We studied the role of two candi-
date genes and found that deletion Irf7 renders the host
highly susceptible to H1N1 infection.
Results
Global expression profiles are distinct in C57BL/6J and
DBA/2J mice
RNA was extracted from the lungs of C57BL/6J and DBA/
2J mice infected with PR8M (a variant of A/Puerto Rico/
8/1934 H1N1) as described in [14], and gene expression
was quantified using RNA sequencing (RNAseq) technol-
ogy. Principal component analysis (PCA) of normalized
counts for host genes confirmed separate groupings of
non-infected (controls) and infected lungs (Fig. 1). The
transcriptome profiles of C57BL/6J mice and DBA/2J mice
were distinct as shown by the second principle compo-
nent, whereas the host response to the infection is mostly
represented by the first principle component which ex-
plains 59 % of the expression variation. PC2 reveals dis-
tinct expression profiles for the two strains due to their
different genetic backgrounds explaining 18 % of the
expression variation. C57BL/6J mice exhibited a change in
transcriptome profiles that was distinct for days 3, 5, 8,
and 14 after infection. However, infected DBA/2J mice
showed an early and stronger change in transcriptome
profiles at day 3 post infection (p.i.) compared to C57BL/
6J. Their expression profile did not show any major
changes until day 5 when DBA/2J mice were moribund.
Expression levels of influenza gene segments correlate
with viral load
In addition to expression profiling of host genes, RNA-
seq also allowed us to investigate transcripts of the eight
viral segments. Expression levels of all influenza seg-
ments (calculated as RPKM: reads which map per kilo-
base of exon model per million mapped reads) changed
in all infected mice over time and were highest at days 3
and 5 p.i. in C57BL/6J mice and at day 3 p.i. in DBA/2J
mice (Fig. 2). In infected C57BL/6J mice, expression sig-
nals from influenza genes strongly decreased on day 8
p.i. and were at baseline levels of mock-treated controls
on day 14 p.i. Expression levels of influenza transcripts
were higher in DBA/2J mice compared to C57BL/6J
mice at days 1 and 3 p.i. Most influenza RNA segments
revealed a similar relative increase in expression, except
for the segment encoding the neuraminidase (‘NA’)
showing a lower increase compared to all other
segments.
Dynamics of the influenza gene expression levels de-
termined by RNASeq correlated well to infectious viral
particles [15] in C57BL/6J and DBA/2J mice (Fig. 3).
Differentially expressed genes overlap with genes
previously identified to be required for viral replication
Differentially expressed genes (DEG) between infected
and mock-treated animals (log-fold change > |0.5|, FDR
Fig. 1 PCA analysis of normalized host gene counts for all samples.
Principle component analysis reveals separate grouping of non-
infected mice and infected mice for both mouse strains. Replicates
for a given day p.i. grouped together well. For C57BL/6J mice,
groups from different days p.i. were well separated. For DBA/2J a
much stronger infection response was observed compared to
C57BL/6J mice and individual mice at days 3 and 5 p.i. were not well
separated. Note that for day 14 p.i., two of three samples were not
separated and only two spots are visible. B6md1, D2md1 and
B6md3, D2md3: C57BL/6J and DBA/2J mice mock-treated and
analyzed at days 1 or 3 post treatment, respectively. Sample labels:
C57BL/6J at days 1, 3, 5, 8 and 14 p.i.: B6d1, B6d3, B6d5, B6d8,
B6d14, respectively; and DBA/2J mice at days 1, 3, 5 p.i.: D2d1, D2d3,
D2d5, respectively
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< 5 %) were determined for C57BL/6J infected mice at
days 3, 5 and 8 p.i and for DBA/2J infected mice at days
3 and 5 p.i. (Table 1). We then compared these DEGs
with genes that were identified previously in siRNA
screens to be important for viral replication [19, 20].
The comparison with a gene list (34 genes) described by
Stertz et al. [20] showed little overlap to our DEG gene
lists (two to seven genes, data not shown). However,
another study [19] used a combination of siRNA experi-
ments and gene expression studies and identified 52
genes. Here, we found an overlap of 18 genes with DEGs
from C57BL/6J and 25 with DEGs from DBA/2J (Table 2).
Eighteen genes were common to both C57BL/6J and
DBA/2J (Table 2, Fig. 4).
From these 25 genes that overlapped with DEGs from
DBA/2J, we selected Irf7 (Interferon regulatory factor 7)
for further studies. We generated an Irf7 knock-out line
on a C57BL/6J background by backcrossing to test the
importance of Irf7 for the host response to influenza
infection. After infection with 2x105 Focus Forming Unit
(FFU) PR8M virus, Irf7−/− mice lost significantly more
body weight and exhibited increased mortality compared
to wild type controls (Fig. 5a, b). These observations
demonstrate that Irf7 plays an important role for the
host defense to influenza A infection.
Host genes involved in virus defense and innate immune
responses strongly correlate with changes in influenza
gene expression
We selected significantly up- or down-regulated genes
(FDR < 0.05 and minimal expression level of log2 = 1; FDR:
false discovery rate) from C57BL/6J infected mice at days
1, 3, 5, 8, and 14 p.i. to identify host genes correlating with
the expression of the viral genome. This analysis was
restricted to C57BL/6J because we aimed to cover the
period of increase in viral load until day 5 p.i. as well as
the clearance phase after day 5 p.i. We found 182 host
genes with a highly correlated expression (169 positively
and 13 negatively) (Spearman correlation coefficient
of larger than |0.8|, and FDR < 0.05) (Table 3,
Fig. 2 Expression levels of influenza genes. Normalized expression
levels for influenza segments (PA, HA, M, NA, NS, PB1, PB2, NP) were
calculated as mean expression values (log2 RPKM + 1), relative to
respective mock treated animals (mock day 1 for day1 infected mice;
mock day 3 for all other days p.i.). Lines represent expression levels
from lungs of C57BL/6J at day 1, 3, 5, 8 and 14 p.i. (B6d1, B6d3, B6d5,
B6d8, B6d14, respectively) and at day 1, 3, 5 p.i. for DBA/2J mice (D2d1,
D2d3, D2d5, respectively). B6mock, D2mock: mock-treated C57BL/6J
and DBA/2J control mice, respectively
Fig. 3 Correlation of expression levels and infectious particles. The part
below the diagonal represents Spearman pairwise correlation factors in
percent as pie charts; the part above the diagonal shows scatter plots
for pairwise comparisons of RPKM and FFU in C57BL/6J and DBA/2J
mice. For C57BL/6J mice, RPKM values from mock day3 and from days
1 to 14 p.i., and for DBA/2J, RPKM values from mock day 3 and days 1
to 5 p.i. were used for the analysis. Data were ordered by day, +1
added and then log2 transformed. FFU were taken from [15], offset by
1 and log2 transformed. Pearson pairwise correlations between RPKM
and FFU for C57BL/6J were: corr = 0.8999419, p-value = 3.676e-07; and
for DBA/2J: cor = 0.8832289, p-value = 0.0001401
Table 1 DEG genes
Comparison DEG-up DEG-down DEG-total
B6d1_B6md1 0 0 0
B6d3_B6md3 1012 325 1337
B6d5_B6md3 935 89 1024
B6d8_B6md3 1444 606 2050
B6d14_B6md3 675 362 1037
D2d1_D2md1 0 0 0
D2d3_D2md3 1383 1042 2425
D2d3_D2md5 2246 2289 4535
Comparison B6-up D2-up DEG-total
B6md1_D2md1 32 50 82
B6md3_D2md3 253 225 478
B6d1_D2d1 49 56 105
B6d3_D2d3 84 114 198
B6d5_D2d5 393 119 512
Number of regulated genes from pairwise comparisons. Analysis was
performed using LIMMA, setting a threshold of more than 1.4-fold (log2 = 0.5)
change in expression levels and FDR < 5 %
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Additional file 1: Table S1). Gene Ontology (GO) en-
richment analyses of positively correlated genes re-
vealed enrichment for terms including ‘host immune
response’, ‘regulation of virus genome replication’, ‘che-
mokine and cytokine production’ and ‘responses to
virus’. Reactome pathway analysis of these 169 posi-
tively correlated genes revealed enrichment for terms
including ‘interferon signaling’, ‘immune system’, and
‘cytokine signaling in immune system’.
Several genes are up-regulated in C57BL/6J mice but not
in DBA/2J mice after infection
C57BL/6J mice exhibit a much lower viral load in their
lungs after infection with H1N1 influenza A virus
(PR8M) compared to DBA/2J mice [14, 15]. Further-
more, the host response in DBA/2J is characterized by a
stronger inflammatory response [14]. Therefore, we
searched for genes that were exclusively up-regulated in
C57BL/6J but not in DBA/2J mice after infection with
PR8M. We hypothesized that these genes may be re-
sponsible for the more efficient control of virus replica-
tion in C57BL/6J mice. In a first step, we performed an
analysis of variance (ANOVA) for all genes in all groups
to identify genes that were significantly up-regulated
(FDR < 10 %). From this set, genes up-regulated only in
C57BL/6J were selected. This filtering identified five
DEGs that were significantly regulated at day 3 and 5 p.i.
in C57BL/6J mice: Lhx2, 2210415F13Rik, Trim15, Reg3g,
and Cd72. The very low expression levels of Lhx2,
2210415F13Rik and Trim15 make it unlikely that these
are crucial candidates mediating the difference in sus-
ceptibility between C57BL/6J and DBA/2J. We therefore
investigated Reg3g (regenerating islet-derived 3 gamma)
in more detail.
Knock-out mice carrying a mutation in the Reg3g gene
on a C57BL/6 N background were infected with influ-
enza PR8M. Differences in body weight loss were ob-
served in mutant compared to wild type mice at day 4 to
Table 2 DEG genes that overlap genes described in siRNA screens
DEG B6d3 DEG B6d5 DEG D2d3 DEG D2d5 DEG B6D2d3 DEG B6D2d5
AREG AREG AREG AREG AREG AREG
ATF3 ATF3 ATF3 ATF3 ATF3 ATF3
B2M B2M B2M B2M B2M B2M
BATF2 CASP1 BATF2 BATF2 BATF2 CD274
CD274 CD274 CASP1 CD274 CD274 CXCL2
CXCL2 CXCL2 CD274 CXCL2 CXCL2 IFI44
DUSP5 IFI44 CXCL2 DUSP5 DUSP5 IRF9
FAM46A IRF9 DUSP5 FKBP11 FAM46A NFKB2
IFI44 NFKB2 FAM46A IFI44 IFI44 PHF11
IRF7 PHF11 IFI44 IL15RA IRF7 STAT1
IRF9 STAT1 IL15RA IRF7 IRF9 TNFAIP2
LCN2 TNFAIP2 IRF7 IRF9 LCN2
LGALS3BP ZC3HAV1 IRF9 LCN2 LGALS3BP
NFKB2 LCN2 LGALS3BP NFKB2
PHF11 LGALS3BP NFKB2 PHF11
RNF114 NFKB2 NFKBIA RNF114
STAT1 NFKBIA PHF11 STAT1








List of DEG genes that overlap with genes described by [19]. DEG B6d3, DEG B6d5 genes expressed differentially in infected C57BL/6J compared to mock-treated
controls on days 3 and 5 p.i., respectively; DEG D2d3, DEG D2d5 genes expressed differentially in infected DBA/2J compared to mock-treated controls on days 3
and 5 p.i., respectively; DEG B6D2d3, DEG B6D2d5: genes expressed differentially in infected C57BL/6J compared to infected DBA/2J mice on days 3 and 5
p.i., respectively
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6 p.i (Fig. 5c). However, no significant difference in sur-
vival was observed between Reg3g knock-out and wild
type C57BL/6 N mice after influenza A virus infection.
Thus, Reg3g seems to play a minor role in the host
defense to influenza virus H1N1 infection.
Discussion
Here, we performed RNAseq based analysis of gene
expression changes in a murine influenza A infection
model by comparing a resistant mouse strain, C57BL/6J,
that survives PR8M (H1N1) infection, with a highly sus-
ceptible strain, DBA/2J, for which infection with PR8M
is lethal. Our studies confirm differences in gene expres-
sion profiles between the two mouse strains that were
described in a previous analysis using microarrays [18].
At day 3 p.i., 670 differentially expressed probesets in
infected C57BL/6J and 1046 in infected DBA/2J mice,
respectively, were identified previously by Alberts and
colleagues [18] and also overlapped with DEGs found in
this study.
Influenza virus transcripts carry a poly(A) tail similar to
host mRNAs. Cellular mRNAs are polyadenylated through
cleavage at the polyadenylation signal and subsequent
addition of the poly(A) tail. In contrast, viral mRNAs obtain
their polyadenylation through a stuttering mechanism in
which the RNA-dependent RNA polymerase moves back
and forth over a stretch of five to seven U residues shortly
before the 5´end [21, 22]. Since we selected poly(A) RNAs
for RNAseq, we were able to investigate expression of viral
genes and, at the same time, to correlate changes in the host
transcriptome with increase and decrease of virus gene ex-
pression. In this way, we could confirm that changes in ex-
pression levels of viral mRNA were correlated with viral
load in the infected lungs. The kinetics of viral replication
over time as well as the difference between C57BL/6J and
DBA/2J was well reflected by changes in sequence counts
determined by RNAseq. Thus, the relative changes in RNA
expression may serve as a surrogate for virus replication
and viral load in infected animals. Thus, RNAseq represents
Fig. 4 Expression changes of DEG genes overlapping with previously
identified genes required for viral replication. The heatmap illustrates
DEG genes from infected C57BL/6J and DBA/2J that overlap with
previously identified genes [19]. Mean expression differences of DEG
genes from infected C57BL/6J and DBA/2J at days 3 and 5 p.i. to
mock-treated samples were calculated and values were scaled by
rows. Colors display z-scores from −1.5 (dark green) to 1.5 (red) for
normalized gene expression values. Rows: name of genes, columns:
difB6d1: difference in expression levels of C57BL/6J infected mice at
day 1 compared to mock day 1 treated animals; difB6d3 to difB6d14:
difference in expression levels of C57BL/6J infected mice at days 3,
5, 8, 15 p.i. compared to mock-treated day 3 animals; difD2d1:
difference in expression levels of DBA/2J infected mice at day 1
compared to mock-treated day 1 animals; difD2d3 to difD2d5:
difference in expression levels of DBA/2J mice infected at days 3,
5 p.i. compared to mock-treated day 3 animals
Fig. 5 Body weight loss of Irf7 and Reg3g knock-out mice after
influenza A infection. Female mice were infected with 2x105 FFU
PR8M by intranasal application. Mice with a weight loss of more
than 30 % of the starting weight had to be euthanized and were
recorded as dead. a Homozygous Irf7−/− mice showed higher body
weight loss (on days 6 to day 8 p.i., p < 0.05, Mann Whitney U test)
and (b) significantly increased mortality (Log-rank test, p < 0.01)
compared to C57BL/6J control mice. c Mutant Reg3g−/− mice exhibited
significant differences in body weight loss at days 4, 5, 6, 9, and 10 p.i.
(Mann Whitney U test, p < 0.05) but no significant increase in mortality
(Log-rank test). Please note that in (a) after day 6 p.i. only the surviving
mice are shown and are thus not representative for the entire group
Wilk et al. BMC Genomics  (2015) 16:655 Page 5 of 10
a big advantage compared to microarrays technology where
a parallel detection of host gene expression and viral gen-
ome expression is not possible.
Zhou et al. [19] combined an siRNA screen with ex-
pression analysis in the human lung epithelial cell line
A549 after infection with PR8 virus. They identified 300
genes as significantly up-regulated and subsequently per-
formed a siRNA screen for those genes. That screen de-
tected 52 genes as regulators of viral replication,
including 40 genes that were not reported previously.
We found 25 genes that overlapped with the 52 genes
identified by [19] (Table 2).
From the 25 overlapping genes, six genes (Stat1, B2m,
Lgals3bp, Dusp5, Nfkbia, Il15ra) were also identified as
host factors involved in influenza virus replication by
Shapira and colleagues [23]. They used human bronchial
epithelial cells for transcriptional profiling and combined
the data with results from a yeast two-hybrid approach
where ten major viral proteins of PR8 were tested
against 12,000 human proteins.
Furthermore, genes acting downstream of RIG-I bind-
ing to viral RNA like Irf7, Irf9, Stat1 and NF-kB were
also found amongst the genes that overlapped with the
list from Zhou et al. [19]. Amongst these factors, IRF7
has been described as an essential key mediator of inter-
feron signaling activation and regulation and has been
shown to be critical for innate immunity [24]. It is con-
stitutively expressed in plasmacytoid dendritic cells
which rapidly produce type I IFN in response to viral
infection [25, 26]. This initial activation triggers a posi-
tive feedback loop regulation of Ifnα and Ifnβ genes by
Irf7 in adjacent cells [27, 28]. The importance of Irf7 in
influenza pathogenesis was also shown in several in vitro
studies [29, 30]. Epithelial cells recognize influenza A
virus via RIG-I/MAVS, leading to the activation of Irf7
and subsequent induction of type I and type III inter-
ferons in redundant amplification loops. In addition, a
recently published study revealed an IRF7-dependent
amplification of IFNs in an influenza patient carrying a
mutation in that gene [31]. In contrast, no in vivo stud-
ies using Irf7 deficient mouse mutants have been pub-
lished so far. Therefore, we selected Irf7 (Interferon
regulatory factor 7) to generate knock-out mice on a
C57BL/6J background by backcrossing and to investigate
its role for host defense in vivo. After infection with
PR8M, Irf7-deficient mice exhibited a more pronounced
body weight loss and increased mortality compared to
wild type mice after infection with H1N1 virus. These
experiments demonstrate the in vivo relevance of Irf7
for the host response to influenza virus infection. Our
studies confirm the potential role of Irf7 in influenza
pathogenesis in an in vivo model system as suggested by
previous in vitro studies [29, 30]. The potential func-
tional roles of all other genes from the list in Table 2 are
discussed in more detail in the supplements.
When comparing results from several RNAi screens
[23, 32–35], Stertz and Shaw identified 34 genes with
potential importance for viral replication that were
found in at least two screens (reviewed in [20]). How-
ever, only seven genes overlapped with the 34 genes in
Table 3 Host genes for which gene expression levels were
highly correlated with influenza gene expression changes in
infected C57BL/6J mice



































List of top 20 positively correlated genes and all negatively correlated genes
(method: Spearman). coeff: Spearman correlation coefficient, adj.p.values:
multiple testing corrected FDR. Genes are sorted by decreasing correlation
coefficients. The complete list is of all correlating genes is provided in
Additional file 1: Table S1
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DBA/2J at day 5 p.i. (Plk3, Rps10, Il17ra, Ptprn, Racgap1,
Nhp2l1, Atp6v0c). One explanation for the small overlap
may be that the RNAi screens were performed in cell
culture whereas our studies identified differentially regu-
lated genes in infected lungs. It should be noted that
transcriptomes in lungs are much more complex due to
the contribution from infiltrating immune cells. Thus,
changes in expression of cultured cells may not reflect
the entire spectrum of host responses well. More future
studies will be necessary to further elucidate this aspect.
Since viral and host transcripts can be followed in the
same individual, we were able to correlate changes in host
gene expression with changes in the level of virus gene
expression. We studied host gene expression in C57BL/6J
lungs and viral transcripts including both the period of in-
creasing viral load (day 1 to day 5 p.i.) as well as the period
of decrease in viral load (day 8 to 14 p.i.). We found 182
host genes that were positively or negatively correlated
with influenza gene expression in infected C57BL/6J mice
(Table 3 shows the 20 positively correlated genes and all
negatively correlated genes). Many of these genes exhibit
well known functions in the host immune response which
are discussed in more detail in the Additional file 2:
Supplemental Material.
In contrast to C57BL/6J mice that survive, DBA/2J mice
die on day six to seven after infection with PR8. A com-
parison of the DEGs in both mouse strains was performed
to identify genes that are exclusively up-regulated in
C57BL/6J. We hypothesize that these genes are candidates
mediating the resistance of C57BL/6J against influenza
infection. We identified two genes (Cd72 and Reg3g) that
were significantly and strongly up-regulated in C57BL/6J
mice compared to DBA/2J. The B cell co-receptor Cd72 is
an important receptor regulating B cell activation [36],
negatively regulating BCR signaling [37] and is addition-
ally expressed on murine NK cells where it acts in an
inhibitory manner through regulating cytokine production
but not cytotoxicity [38]. In C57BL/6J we observed a two-
fold higher up-regulation of Cd72 compared to DBA/2J.
The resulting deficit in the inhibitory effect on NK cells
and the following diminished regulation of cytokine
amounts may be a good explanation for the exaggerated
immune response observed in DBA/2J mice. More experi-
ments will be needed to evaluate the possible role of Cd72
for the host response to influenza A virus.
For Reg3g an increase in expression levels was observed
in IBD (inflammatory bowel disease), a murine bacterial
reconstitution model [39] and after experimental intestinal
infection with Listeria monocytogenes [40]. The role of
Reg3g in lung infection was further elucidated by Choi et
al. [41]. They were able to show that Reg3g expression is
regulated by Stat3 and highly increased after MRSA
(Methicillin-resistant Staphylococcus aureus) infection in
the lung epithelium. Administration of recombinant Reg3g
was able to restore mucosal immunity against MRSA in
vivo, highlighting the therapeutic potential for Reg3g [41].
The fact that Reg3g was up-regulated in C57BL/6J, but not
in DBA/2J may account for the differences in disease out-
come. We therefore studied the possible role of Reg3g in
knock-out mice. However, despite its strong up-regulation
after influenza virus infection, deletion of this gene had no
strong effect on the susceptibility of the host to infections
with H1N1. It may, however, be possible that Reg3g defi-
cient mice are susceptible to other influenza virus sub-
types or other viral infections.
Conclusions
In conclusion, using RNAseq analysis we identified novel
genes important for viral replication or host defense.
This study adds further important knowledge to host-
pathogen-interactions and suggests additional candidates




All experiments in mice were approved by an external
committee according to the German national guidelines
of the animal welfare law. The protocol used in these
experiments has been reviewed and approved by an
ethics committee as described in the regulations from
the German Bundesministerium für Ernährung, Land-
wirtschaft und Verbraucherschutzand, and detailed in
the “Tierschutzkommissions-Verordnung vom 23. Juni
1987 (BGBl. I S. 1557)” (http://www.gesetze-im-internet.de/
bundesrecht/tierschkomv/gesamt.pdf). Subsequently, the
protocol has been formally approved by the ‘Niedersäch-
sisches Landesamt für Verbraucherschutz und Lebensmit-
telsicherheit, Oldenburg, Germany’ (Permit Number:
3392 42502-04-13/1234).
Virus and mice
The mouse-adapted virus strain influenza A/Puerto
Rico/8/1934 H1N1 (PR8M) was produced as described
previously [14, 42]. C57BL/6J and DBA/2J mice were
obtained from Janvier, France. Mutant B6;129P2-
Irf7tm1Ttg were kindly provided by Tadatsugu Taniguchi
[24]. B6;129P2-Irf7tm1Ttg mice were backcrossed to
C57BL/6J for 12 generations to generate B6.129P2-
Irf7tm1Ttg mice (Irf7−/−). The background was confirmed
by SNP-genotyping (Mouse Universal Genotyping Array
(MUGA), Neogen Corporation, USA). The Reg3g
knock-out mouse strain was created from ES cell clone
EPD0309_D08, obtained from the KOMP Repository
(www.komp.org) to generate B6-Reg3gtm1a(KOMP)Wtsi
(Reg3g−/−) mice.
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Mouse infections
Female, 10–12 weeks old mice were anesthetized by intra-
peritoneal injection with Ketamine/Xylazine (85 % NaCl
(0.9 %), 10 % Ketamine, 5 % Xylazine) with doses adjusted
to the individual body weight. Mice were then intranasally
infected with 20 μl virus solution (2x103 (RNASeq) or
2x105 (knock-out mice) FFU PR8M) or mock-infected
with PBS.
RNA isolation
Mice were sacrificed and entire lungs were extracted
from mice from both strains on days 1, 3 and 5 after in-
fection. For mock-infected animals, mice were sacrificed
at days 1 and 3 post treatment. In addition, lungs from
C57BL/6J mice were also collected on days 8 and 14.
For every treatment and day post infection (p.i.) 4–5
mice were prepared. The lungs were immediately trans-
ferred to RNAlater solution (Qiagen), kept at 4 °C for
one day and subsequently stored at −20 °C. RNA was
isolated using Qiagen Midi Kit as described previously
[43]. RNA quality was controlled on a 2100 Bioanalyzer
Instrument (Agilent). All RNA samples had a RNA
Integrity Number (RIN) of ≥ 9.7. Three independent bio-
logical replicates were selected for each time point for
subsequent RNA sequencing.
RNAseq library preparation, sequencing and analysis
Twenty μg of total RNA was enriched for poly A+ RNA
using one cycle of the Poly A Purist Kit from Ambion
according to the manufacturer’s standard protocol. The
resulting enriched RNA samples were analyzed on an
Agilent Bioanalyzer to determine the remaining amount
of rRNA in the samples. If the amount was higher than
5 %, samples were subjected to another cycle of Poly A
enrichment. One-hundred ng of the poly A+ enriched
RNA was then used to prepare libraries for sequencing
using the AB Library Builder™ Whole Transcriptome
Core Kit for 5500 Genetic Analysis Systems on a Library
Builder system. Libraries were amplified for 15 cycles
before 5500 Wildfire primers were added using five cy-
cles of fusion primer amplification as directed in the
5500 Wildfire manual. Before sequencing, small aliquots
of libraries were pooled and sequenced on an Ion Tor-
rent PGM 314 chip after additional amplification with
PGM fusion primers. The library pools were quantified
by Real-Time PCR and immobilized on flow cells for the
SOLiD 5500 Wildfire instrument (Applied Biosystems)
and sequenced (50 bp reads). The average number of
reads per sample was 29.5. One sample had a high num-
ber of reads (230 million), and the others on average had 23
million reads. The mouse reference genome (GRCm38/
mm10) was downloaded from ftp://hgdownload.cse.ucsc.
edu/goldenPath/mm10/chromosomes/. Sequencing reads
(XSQ format) from C57BL/6J samples were aligned to the
C57BL/6J reference genome using the Whole Transcrip-
tome mapping module of the LifeScope 2.5.1 software
(http://www.lifetechnologies.com/lifescope). Similarly, se-
quencing reads from DBA/2J samples were aligned to the
enhanced DBA/2J genome that was generated by substitut-
ing ~4.5 million DBA/2J SNPs in the reference genome.
Filter reference containing polyA, polyC, polyG, polyT,
rRNAs, tRNAs, as well as adaptor, barcode, and primer
sequences was used to remove non-mRNAs reads prior to
the mapping. We used the mouse RefSeq transcript anno-
tation downloaded from UCSC genome browser (www.
genome.ucsc.edu) to generate a junction reference library
containing a list of exon-exon pairs. Reads were aligned
against both the reference genome and the junction li-
brary. Reads that could not be mapped were realigned
against the H1N1 viral contigs. Reads with minimum
mapping quality of 10 were used to generate raw counts
to be used for downstream differential and correlation
analysis.
Bioinformatic analysis
Raw read counts were used for analysis with DESeq2 [44]
statistical package after adding 1 to all values. The DESeq
function rlogTransformation was used to normalize and
log transform raw read counts and to calculate normalized
expression counts. The normalized expression counts were
then used for further analysis without applying any add-
itional pre-processing filtering. Principal component ana-
lysis analysis and identification of differentially expressed
genes were performed using DESeq2. DEGs were selected
based on an adjusted p-value of 0.05 (FDR of 5 %) and
exhibiting at least a 1.4-fold difference in expression levels
(log2 = 0.5). Strip charts, scatter plots and heat maps were
generated using the R software package [45]. Multi-group
comparisons were performed with the LIMMA package
[46] using BH correction for multiple testing [47]. Cell sig-
nature genes were identified based on the BioGPS database
(GEO database ID GSE10246) and our previous analysis of
gene expression patterns in a non-lethal infection [17].
Inflammatory genes that are expressed during influenza in-
fections were selected based on our previous influenza
transcriptome studies [17, 43]. For analysis of influenza
transcripts, log2-transformed RPKM values were calculated
from counts of sequences that aligned to influenza gene
segments. Analysis of correlations between influenza (log2
RPKM counts of the sum of all genes) and host gene (nor-
malized log2 counts) expression levels was performed with
the R function cor using Spearman as method. Correlation
graphs were generated using the R package ‘corrgram’ [48].
Adjusted p-values for correlated genes were calculated as
FDR using cor.test. GO enrichment analysis and Reactome
enrichment analysis (using the full gene list from normal-
ized counts as reference) was performed with the R package
clusterProfiler [49].
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